Multiple Myeloma Clinical Trial

Real World Treatment Experience of Patients With Breast, Lung, or GI Cancer or Multiple Myeloma Using Remote Symptom Monitoring

Summary

The Carevive registry collects patient characteristics, patient symptoms, and treatment experience data from patients receiving cancer treatment for breast, lung, GI or multiple myeloma. For this study, a core set of variables is collected on each patient in the Carevive platform. Patients will complete a baseline survey in person using a secured device or remotely using their own electronic device in a location of their choice. Weekly electronic Patient Reported Outcome surveys are collected from the patients using the Carevive platform for a minimum of 12 weeks. Patients may continue weekly surveys as long as they are receiving treatment.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

All participants must be 18 years of age or older.
Subjects may be any stage and anywhere in the treatment continuum.
Subject participants must have a diagnosis of breast, lung, GI or ovarian cancer or multiple myeloma.
Subjects must be able to complete on-line surveys using a cell phone, tablet, or computer.
All participants must be able to understand English.

Exclusion Criteria:

Any patient who cannot understand written or spoken English.
Any patient without the ability to complete on-line surveys using a cell phone, tablet, or computer.
Any patient on a treatment clinical trial.
Any prisoner and/or other vulnerable persons as defined by NIH (45 CFR 46, Subpart B, C and D).

Study is for people with:

Multiple Myeloma

Estimated Enrollment:

100

Study ID:

NCT05587972

Recruitment Status:

Recruiting

Sponsor:

Carevive Systems, Inc.

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Cleveland Clinic
Cleveland Ohio, 44131, United States More Info
LIsa Mirossay
Contact
216-986-4427
[email protected]g

How clear is this clinincal trial information?

Study is for people with:

Multiple Myeloma

Estimated Enrollment:

100

Study ID:

NCT05587972

Recruitment Status:

Recruiting

Sponsor:


Carevive Systems, Inc.

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.